Granite Harbor Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$764K Buy
5,942
+257
+5% +$30.1K 0.3% 61
2026
Q1
$684K Buy
5,685
+148
+3% +$17.1K 0.3% 67
2025
Q4
$583K Buy
5,537
+469
+9% +$44K 0.25% 65
2025
Q3
$425K Buy
5,068
+473
+10% +$39K 0.18% 87
2025
Q2
$364K Buy
4,595
+932
+25% +$74.1K 0.17% 85
2025
Q1
$329K Buy
3,663
+842
+30% +$78.6K 0.17% 79
2024
Q4
$281K Buy
2,821
+64
+2% +$6.6K 0.16% 75
2024
Q3
$313K Buy
2,757
+880
+47% +$105K 0.18% 74
2024
Q2
$232K Buy
1,877
+100
+6% +$12.9K 0.15% 75
2024
Q1
$234K Buy
+1,777
New +$219K 0.16% 72

Other funds holding MRK

Granite Harbor Advisors's MRK Position: Q2 2026 in Review

Granite Harbor Advisors increased its Merck (MRK) stake by 4.5% in Q2 2026, buying an estimated $30.1K and bringing the position to 5,942 shares worth $764K. The position accounts for 0.3% of the portfolio, ranked #61.

Granite Harbor Advisors first reported a position in MRK in Q1 2024 and has held it in 10 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Granite Harbor Advisors held 5,942 shares of Merck worth $764K as of Q2 2026.
  • Granite Harbor Advisors bought 257 Merck shares in Q2 2026, an estimated $30.1K.
  • Merck made up 0.3% of Granite Harbor Advisors's portfolio in Q2 2026, its #61 holding.
  • Granite Harbor Advisors first reported a position in Merck in Q1 2024 and has held it in 10 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Granite Harbor Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.